Email Us
View Reports

Hemostats Market

Global Hemostats Market Analysis - By Product (Thrombin-Based & Oxidized Regenerated Cellulose-Based,), By Formulation (Matrix & Gel, Sheet & Pad,) By Application (Orthopedic Surgery & General Surgery), By Region (North America (United States & Canada), Europe (United Kingdom, Italy, Germany, Spain, France & Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Mexico, Argentina & Rest of Latin America), Middle East & Africa) - Global Industry Size, Share, Growth, Demand, strategy & Forecast | 2019 - 2025

  • ID : 11519021  |  
  • Published : Oct-2019  |  
  • Region : Global  |  
  • Pages : 140   |  
  • Publisher : Bizwit Research & Consulting LLP

Hemostats Market Size, Trends & Forecast (2019 - 2025)

According to the research report, the Hemostats Market Size is expected to be valued at USD xx billion in 2019 is anticipated to grow USD xx billion with the compounded annual growth of xx.x% over the forecast period 2019 - 2025.

  • The increasing number of hospitals and surgical centers is anticipated for further growth in the hemostats market in the upcoming period.

  • However, the increase in funding in R&D, as well as advancement in technology, had led to an increase the market growth. In another word, we can say hemostats as arterial forceps or hemostatic clamp.

  • Generally, the hemostat is a surgical tool that is used during major surgical procedures in order to control blood loss or halt bleeding during surgery.

  • Hemostats consists of a group of instruments that include pivot, tissue holders, needle holders, and various clamps.

  • Due to the presence of a pool of patients throughout the world, the Hemostats market is tremendously growing day by day.

Hemostats Market - Research Objectives

  • To explain the definition and scope of the research study based on crop type, form, mode of application and region.

  • Estimate the current market size and forecast the same for 2017 to 2025

  • Market size breakdown for each of the segments and regions analyzed

  • Insights on the major market dynamics (drivers, restraints & opportunities) and their impact analysis for the analysis period

  • Micro and macro-level analysis of the market to elucidate imminent investment opportunities

  • Porter’s Five forces analysis to deliver a comprehensive buyer-seller scenario and the state of the business environment

  • Identification of the Agricultural Micronutrients Market trends in the current scenario as well as growth indicators

  • Benchmarking leading vendors in the Agricultural Micronutrients Industry based on their strategic attempts, financial status, and other internal and external parameters

This Research Report includes the Segmentation of Hemostats Market:

Hemostats Market - By Product

  • Thrombin-Based Hemostats

  • Oxidized Regenerated Cellulose-Based Hemostats

  • Combination Hemostats

  • Gelatin-Based Hemostats

  • Collagen-Based Hemostats

Hemostats Market - By Formulation

  • Matrix & Gel Hemostats

  • Sheet & Pad Hemostats

  • Sponge Hemostats

  • Powder Hemostats

Hemostats Market - By Application

  • Orthopedic Surgery

  • General Surgery

  • Neurological Surgery

  • Cardiovascular Surgery

  • Reconstructive Surgery

  • Gynecological Surgery

  • Others Surgery

Hemostats Market – By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Rest of the World

Regionally, North America is expected to account for the substantial part of the global Hemostats Market in the years ahead. The market in North America is well-established, with the US doing a major contribution to the entire region. Growth in the North American business is majorly driven by the increasing geriatric population and an increasing number of surgeries in the USA and Canada.

Dominating Companies Listed in the Research Report Hemostats Market:

  1. CR Bard

  2. B. Braun Melsungen AG (Germany), Inc. (US)

  3. Integra LifeSciences (US)

  4. Baxter International, Inc. (US)

  5. Marine Polymer Technologies

  6. Teleflex (US)

  7. Ethicon, Inc. (US)

  8. Z-Medica LLC (US)

  9. Pfizer, Inc. (US)

  10. Gelita Medical GmbH (Germany).

** Our research team can customize this research report as per your needs/queries. Please write your thoughts to sales@researchcosmos.com

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Key Trends

1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

1.3.1. Global Hemostats Market, by Region, 2015-2025 (USD Billion)

1.3.2. Global Hemostats Market, by Product, 2015-2025 (USD Billion)

1.3.3. Global Hemostats Market, by Formulation, 2015-2025 (USD Billion)

1.3.4. Global Hemostats Market, by Application, 2015-2025 (USD Billion)

1.4. Estimation Methodology

Chapter 2. Global Hemostats Market Definition and Scope

2.1. Research Objective

2.2. Market Definition& Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

2.5. Report Limitation

Chapter 3. Global Hemostats Market Dynamics

3.1. See Saw Analysis

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Hemostats Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Buyers

4.1.2. Bargaining Power of Suppliers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model

4.2. PEST Analysis

4.2.1. Political Scenario

4.2.2. Economic Scenario

4.2.3. Social Scenario

4.2.4. Technological Scenario

4.3. Value Chain Analysis

4.3.1. Supplier

4.3.2. Manufacturers/Service Provider

4.3.3. Distributors

4.3.4. End-Users

4.4. Key Buying Criteria

4.5. Regulatory Framework

4.6. Cost Structure Analysis

4.6.1. Raw Material Cost Analysis

4.6.2. Manufacturing Cost Analysis

4.6.3. Labour Cost Analysis

4.7. Investment Vs Adoption Scenario

4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Hemostats Market, By Product

5.1. Market Snapshot

5.2. Market Performance – Potential Model

5.3. Global Hemostats Market, Sub Segment Analysis

5.3.1. Thrombin-Based Hemostats

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2. Oxidized Regenerated Cellulose-Based Hemostats

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.3. Combination Hemostats

5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.4. Gelatin-Based Hemostats

5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.2 Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.5. Collagen-Based Hemostats

5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Hemostats Market, By Formulation

6.1. Market Snapshot

6.2. Market Performance – Potential Model

6.3. Global Hemostats Market, Sub Segment Analysis

6.3.1. Matrix & Gel Hemostats

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2. Sheet & Pad Hemostats

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3. Sponge Hemostats

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4. Powder Hemostats

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Hemostats Market, By Application

7.1. Market Snapshot

7.2. Market Performance – Potential Model

7.3. Global Hemostats Market, Sub Segment Analysis

7.3.1. Orthopedic Surgery

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2. General Surgery

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3. Neurological Surgery

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4. Cardiovascular Surgery

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.5. Reconstructive Surgery

7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.6. Gynaecological Surgery

7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.7. Other Surgery

7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Hemostats Market, by Regional Analysis

8.1. Hemostats Market, Regional Market Snapshot (2015-2025)

8.2. North America Hemostats Market Snapshot

8.2.1. U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2. Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3. Europe Hemostats Market Snapshot

8.3.1. U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2. Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3. France

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4. Rest of Europe

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4. Asia Hemostats Market Snapshot

8.4.1. China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2. India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3. Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4. Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Hemostats Market Snapshot

8.5.1. Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6. Rest of The World

8.6.1. South America

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2. Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence

9.1. Company Market Share (Subject to Data Availability)

9.2. Top Market Strategies

9.3. Company Profiles

9.3.1. C. R. Bard

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2. B.Braun

9.3.3. Baxter

9.3.4. Integra Lifesciences

9.3.5. Marine Polymer Technologies

9.3.6. Pfizer

9.3.7. Gelita Medical GmbH

9.3.8. Z-Medica, LLC

9.3.9. Ethicon (Subsidiary of Johnson & Johnson)

9.3.10. Teleflex Incorporated

9.3.11. CSL Behring

9.3.12. Cryolife, INC.

9.3.13. B Braun Melsungen AG

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.1.6. Research Assumption

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?